Restoring Study 329: efficacy and harms of paroxetine and imipramine. https://t.co/znW77ZrGgJ Important stuff you may have missed
Misreported @GSK study supporting using #depression drugs in teens actually shows no clinical benefit & more harming https://t.co/i3K92xTLqO
RT @uchida_kawasaki: 抗うつ薬のパロキセチン「若い人には効果なし」、有力医学誌で再検証の報告 | Medエッジ https://t.co/PGFEdoMvjX http://t.co/v5uFK3u3pl http://t.co/6CzjPzoMV7
RT @uchida_kawasaki: 抗うつ薬のパロキセチン「若い人には効果なし」、有力医学誌で再検証の報告 | Medエッジ https://t.co/PGFEdoMvjX http://t.co/v5uFK3u3pl http://t.co/6CzjPzoMV7
RT @uchida_kawasaki: 抗うつ薬のパロキセチン「若い人には効果なし」、有力医学誌で再検証の報告 | Medエッジ https://t.co/PGFEdoMvjX http://t.co/v5uFK3u3pl http://t.co/6CzjPzoMV7
BMJ article on Study 329 (paxil in adol.) that raises serious questions about AE reporting #EBP http://t.co/g0npffpT8T
.@andrewpurcellny you might be interested #RestoringStudy329 http://t.co/F5iZ7brzoF re problems re reporting trials incl. antidepressants
Restoring Study 329: efficacy&harms of paroxetine&imipramine in Rx of major depressn in adolescence http://t.co/24KE5EeE8S via @bmj_latest
Comment on Le Noury J (2015): Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment http://t.co/4PaumCeZsn
未読論文メモ [パロキセチンBMJ] http://t.co/Vyb7UIaQzG [ニコチンNEJM] http://t.co/u6z7zHSLKt [アセトアミノフェンNEJM] http://t.co/Y8zQnzcgZZ
RT @TeenHealthMD: #Paroxetine ineffective and harmful for treating #adolescent #depression http://t.co/vnSznR23pK #bmj
Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM https://t.co/62yGAZ6t0d
Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence - the BMJ https://t.co/2xzuEUzBdz
RT @briandavidearp: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence - important read http:/…
RT @briandavidearp: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence - important read http:/…
Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence - important read http://t.co/3A8PfFw5ZE
パキシルもトフラニールも青年期の大うつ病に効果なし http://t.co/zPfj2QYC5x
RT @ShaminiJain: Data revisited: paroxetine and imipramine in treatment of major depression in adolescence show no efficacy, show harm http…
Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/8glJJkVo3S
The BMJ admit paroxetine for depressed adolescents is harmful after all - original Smithkline Beecham study is false http://t.co/wq3CbOboMU
An example of why studies funded by corporations with vested interests must be replicated before being put into... http://t.co/5A1gkQGINp
Data revisited: paroxetine and imipramine in treatment of major depression in adolescence show no efficacy, show harm http://t.co/pjbC5F9sZR
RT @uchida_kawasaki: 抗うつ薬のパロキセチン「若い人には効果なし」、有力医学誌で再検証の報告 | Medエッジ https://t.co/PGFEdoMvjX http://t.co/v5uFK3u3pl http://t.co/6CzjPzoMV7
抗うつ薬のパロキセチン「若い人には効果なし」、有力医学誌で再検証の報告 | Medエッジ https://t.co/PGFEdoMvjX http://t.co/v5uFK3u3pl http://t.co/6CzjPzoMV7
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
RT @trished: Delegate asks if @GSK will take paroxetine off market in light of Study 329's restoration #RIAT http://t.co/vvHjI7XWbK #resear…
RT @trished: Delegate asks if @GSK will take paroxetine off market in light of Study 329's restoration #RIAT http://t.co/vvHjI7XWbK #resear…
RT @trished: Delegate asks if @GSK will take paroxetine off market in light of Study 329's restoration #RIAT http://t.co/vvHjI7XWbK #resear…
Delegate asks if @GSK will take paroxetine off market in light of Study 329's restoration #RIAT http://t.co/vvHjI7XWbK #researchwaste15
Study 329: Data Wars http://t.co/W04pYprNQg Via @DrDavidHealy and @bmj_latest Rapid Responses here - http://t.co/j6IKiACazt
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/l19X3GriIt
BBB (13 of X): Also in the news - reanalysis of 14 yr old Paxil teen study shows no effectiveness and higher suicide. http://t.co/5diJCkVHcu
Importante! http://t.co/xCkXM5FwHT
Articolo bomba su BMJ sugli effetti (nulli) di Paroxetina e Imipramina sulla depressione maggiore di adolescenti.... http://t.co/vX6mmf4m9t
RT @eupatients: Restoring invisible and abandoned trials #bmj_news Study 329 + video http://t.co/QtO1wAIbHc
Restoring invisible and abandoned trials #bmj_news Study 329 + video http://t.co/QtO1wAIbHc
@juliamedew http://t.co/jKcLdN75Uf Re-analysis suggests this SSRI may not be so fancy after all!
RT @MartinWinckler: Ailleurs sur le front contre Big Pharma : la paroxétine ni efficace, ni sûre ds la dépression grave de l'adolescent. ht…
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
No real consequences for authors who intentionally misreport trials. Why? Hope they all get everlasting diarrhoea. http://t.co/kqKed0BQMR
RT @MartinWinckler: Ailleurs sur le front contre Big Pharma : la paroxétine ni efficace, ni sûre ds la dépression grave de l'adolescent. ht…
Ailleurs sur le front contre Big Pharma : la paroxétine ni efficace, ni sûre ds la dépression grave de l'adolescent. http://t.co/QLsd2snM6k
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/ymI0gCtaqV
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major... http://t.co/6WG7u9gT4e
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/sq6ncYSLgc
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/fYcPH9JeuK
#Study329: We demand an institutional response [response to #RestoringStudy329] http://t.co/F5iZ7brzoF
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @FarmaciaOesteAP: (BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) h…
RT @bmj_latest: Reanalysis of antidepressant trial contradicts original findings & has important implications for research practice http://…
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
RT @marcecolomer: La peor mentira: manipular datos en investigación médica y ensayos clínicos: #Study329 Paroxetina http://t.co/pVjJuuK800
RT @JuanGrvas: Antidepresivos en adolescentes. Medicamentos que no funcionan y dañan. ¡Pobres pacientes y sus familias! http://t.co/olcv09C…
RT @bmj_latest: Reanalysis of antidepressant trial contradicts original findings & has important implications for research practice http://…
RT @drahincapie: la #paroxetina y la #imipramina no son seguras ni efectivas para tratar la #depresionadolescente. http://t.co/X7UMbMrf3A
RT @rincondesisifo: (BMJ) Paroxetina e imipramina a la luz de la evidencia: reevaluación del estudio 329 http://t.co/Al2HnWaJIH Ineficaces…
La peor mentira: manipular datos en investigación médica y ensayos clínicos: #Study329 Paroxetina http://t.co/pVjJuuK800
An argument for open trial data: http://t.co/2EEJ919A8O
RT @psychepi: #RestoringStudy329 - more responses http://t.co/F5iZ7brzoF including Elia Abi-Jaoude & me, drawing attention to undeclared #C…
(BMJ) Paroxetina e imipramina para depresión mayor en adolescentes: sin eficacia y riesgo de RAM (reanálisis de ECA) http://t.co/CbYie4T6br
#RestoringStudy329 - more responses http://t.co/F5iZ7brzoF including Elia Abi-Jaoude & me, drawing attention to undeclared #COI by critic
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/joEvqL4yxu
Reanalysis of #depression drug shows it is not effective but unsafe for #adolescents http://t.co/T3WGNnKi7x #drugtrials
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
RT @bmj_latest: Reanalysis of antidepressant trial contradicts original findings & has important implications for research practice http://…
RT @bmj_latest: Reanalysis of antidepressant trial contradicts original findings & has important implications for research practice http://…
Re-analyzing Study 329 - Safety of Paxil for adolescent depression http://t.co/FULmC9P9JB #bigpharma
RT @andrewdstreet: Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence htt…
RT @enriquegavilan: Compara artículo original http://t.co/b9N7bw6Wk8 con reanálisis posterior independiente http://t.co/NgHtnyNexx #Estudio…
@stephensenn @david_colquhoun I think this proves the case for access to primary data from drug companies. http://t.co/i7cw6vfu2i
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/vs6szOjZT1
RT @rincondesisifo: (BMJ) Paroxetina e imipramina a la luz de la evidencia: reevaluación del estudio 329 http://t.co/Al2HnWaJIH Ineficaces…
RT @DogICUma: This is extremely alarming http://t.co/gzLAPsYVRN
¿Un antidepresivo falsamente seguro para los adolescentes? http://t.co/7dxA6rKFtP Información adicional: http://t.co/6xGw06IDEd
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/myEBsfNcyf
The paroxetine study reviewed: http://t.co/hRTWKXLJ4D
RT @alfonso_casi: Ni la paroxetina ni imipramina tienen eficacia en la depresión mayor de los adolecentes, pero sí efectos adversos!! http:…
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/eRkQNEbhxY
RT @Nannon_Phillips: @fgodlee talks about RIAT initiative, encouraging reanalysis of contentious data, e.g. Paroxetine trial http://t.co/1b…
RT @Nannon_Phillips: @fgodlee talks about RIAT initiative, encouraging reanalysis of contentious data, e.g. Paroxetine trial http://t.co/1b…
@fgodlee talks about RIAT initiative, encouraging reanalysis of contentious data, e.g. Paroxetine trial http://t.co/1bXteAMjox #primecentre
The efficacy of paroxetine & imipramine was not statistically or clinically significantly different from placebo... http://t.co/PE11AwJRfC
RT @DogICUma: This is extremely alarming http://t.co/gzLAPsYVRN
RT @DrDavidHealy: Not Safe, Not Effective: Our re-analysis of 2001 #Study329 of Paxil/Seroxat for teen depression, free to all in BMJ. http…
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/HxPc272VT8
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/ELLsH3CrO0
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence http://t.co/yAgIHCevXv
RT @DogICUma: This is extremely alarming http://t.co/gzLAPsYVRN
Restoring Study 329: efficacy and harms of paroxetine and imipramine | wow... http://t.co/yB9lNK63uw
#AntiDepressants Are you sure yours is not harmful and is effective? http://t.co/sxxzeb01Du
RT @bmj_latest: Antidepressant isn't safe or effective in teens, says re-analysis of major study http://t.co/D4ENu0UoWg The BMJ: http://t.c…